Role of N-acetylcysteine in liver injury due to dengue fever.
Monica GuptaSamiksha GuptaDhriti SoodAkanksha GuptaGautam JesraniPublished in: Tropical doctor (2023)
Dengue fever (DF) is a common mosquito-borne viral infection which is endemic in Southeast Asia. Liver involvement may vary from asymptomatic elevation of liver enzymes to fulminant hepatitis. Although the valuable effects of N-acetylcysteine (NAC) in paracetamol toxicity and non-paracetamol liver failure have been extensively studied, its use in DF-associated hepatitis remains unclear. We made a literature search in an online format from libraries such as PubMed, Google Scholar, and EMBASE, and selected 33 articles including original research articles, case reports, and systemic analyses. The majority of the articles reviewed had a positive outcome but treatment strategies involved NAC together with supportive care. Hence, data on sole use of NAC from large randomised control trials remain unclear.
Keyphrases
- liver failure
- liver injury
- aedes aegypti
- drug induced
- transcription factor
- dengue virus
- zika virus
- hepatitis b virus
- clinical trial
- genome wide analysis
- healthcare
- palliative care
- systematic review
- multidrug resistant
- oxidative stress
- electronic health record
- open label
- study protocol
- randomized controlled trial
- anti inflammatory drugs
- double blind
- pain management
- machine learning
- artificial intelligence